Amazeen Pharmaceuticals Private Limited
About Amazeen Pharmaceuticals Private Limited
Data last updated:
Amazeen Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 01 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC280967. Its GSTIN is 07AANCA5189N1ZW (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Digamber Sah and Nagmani Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 259 – A Gali No. – 5 Block D Sangam Vihar, New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.03 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹41,871 (net margin 0.4%) and EBITDA of ₹52,329 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Amazeen Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 259 – A Gali No. – 5 Block D Sangam Vihar, New Delhi, Delhi, India – 110062
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Amazeen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amazeen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amazeen Pharmaceuticals Private Limited, buy the company report.
Financials of Amazeen Pharmaceuticals Private Limited
FY 2025 filings availableAmazeen Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 39% growth in the latest year. EBITDA rose 303% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52,329 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41,871 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amazeen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amazeen Pharmaceuticals Private Limited
Amazeen Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Digamber Sah Also directs: Novitas Remedies Private Limited | Director | 01 Jun 2015 | 11 Years 5 Months | Current |
| Nagmani Kumar | Director | 01 Jun 2015 | 11 Years 5 Months | Current |
Auditor
Amazeen Pharmaceuticals Private Limited is audited by ATUL YADAV & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL YADAV & COMPANY | FY 2017 | 027684N |
Shareholding
The shareholding of Amazeen Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Amazeen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amazeen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amazeen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amazeen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCA5189N1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amazeen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amazeen Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Digamber Sah was appointed as Director on 01 Jun 2015.
Frequently asked questions
Amazeen Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 01 June 2015 (11+ years old) and is registered under CIN U24100DL2015PTC280967.
Amazeen Pharmaceuticals has 2 current directors:
- Digamber Sah - Director
- Nagmani Kumar - Director
The latest financial statements of Amazeen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Amazeen Pharmaceuticals is 07AANCA5189N1ZW, registered in Delhi.
The CIN (Corporate Identification Number) of Amazeen Pharmaceuticals is U24100DL2015PTC280967. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amazeen Pharmaceuticals was incorporated on 01 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Digamber Sah was appointed as Director on 01 Jun 2015. Nagmani Kumar was appointed as Director on 01 Jun 2015.
The registered office of Amazeen Pharmaceuticals is at H.No. 259 – A Gali No. – 5 Block D Sangam Vihar, New Delhi, Delhi, India – 110062.
Amazeen Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Amazeen Pharmaceuticals is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
